| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.15 | 0.3 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.3 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |